Home LiteratureArticle Details
PMID: 15471963 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Validation Study

A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.

Endocrinology ·Vol. 146 ·No. 1 ·2005-01-00 ·Pages 13-8

Barclay WW, Woodruff RD, Hall MC, Cramer SD

Abstract

The development of normal and abnormal glandular structures in the prostate is controlled at the endocrine and paracrine levels by reciprocal interactions between epithelium and stroma. To study these processes, it is useful to have an efficient method of tissue acquisition for reproducible isolation of cells from defined histologies. Here we assessed the utility of a standardized system for acquisition and growth of prostatic cells from different regions of the prostate with different pathologies, and we compared the abilities of stromal cells from normal peripheral zone, benign prostatic hyperplasia (BPH-S), and cancer to induce the growth of a human prostatic epithelial cell line (BPH-1) in vivo. Using the tissue recombination method, we showed that grafting stromal cells (from any histology) alone or BPH-1 epithelial cells alone produced no visible grafts. Recombining stromal cells from normal peripheral zone with BPH-1 cells also produced no visible grafts (n = 15). Recombining BPH-S with BPH-1 cells generated small, well-organized, and sharply demarcated grafts approximately 3-4 mm in diameter (n = 9), demonstrating a moderate inductive ability of BPH-S. Recombining stromal cells from cancer with BPH-1 cells generated highly disorganized grafts that completely surrounded the host kidney and invaded into adjacent renal tissue, demonstrating induction of an aggressive phenotype. We conclude that acquisition of tissue from toluidine blue dye-stained specimens is an efficient method to generate high-quality epithelial and/or stromal cultures. Stromal cells derived by this method from areas of BPH and cancer induce epithelial cell growth in vivo, which mimics the natural history of these diseases.

MeSH Terms
Cell Communication Cell Division Cell Line Coloring Agents Endocrinology/methods Epithelial Cells/pathology Humans Male Prostate/pathology Prostatic Hyperplasia/pathology,physiopathology Prostatic Neoplasms/pathology,physiopathology Specimen Handling/methods Stromal Cells Tolonium Chloride
Chemicals
Coloring Agents Tolonium Chloride
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Barclay Wendy W
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
Woodruff Ralph D
Hall M Craig
Cramer Scott D
References (20)
20 references, click to expand
  1. Pathology of benign prostatic hyperplasia. Insight into etiology.
    Urol Clin North Am. 1990 Aug;17(3):477-86 PMID: 1695776
  2. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  3. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):265-70 PMID: 10750664
  4. Method for procuring specific populations of viable human prostate cells for research.
    Lab Invest. 2001 Apr;81(4):501-7 PMID: 11304569
  5. Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth.
    J Nutr. 2002 Oct;132(10):3191-4 PMID: 12368417
  6. Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis.
    J Biol Chem. 2002 Nov 15;277(46):44475-84 PMID: 12191999
  7. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation.
    Differentiation. 2002 Dec;70(9-10):547-60 PMID: 12492496
  8. Are primary cultures realistic models of prostate cancer?
    J Cell Biochem. 2004 Jan 1;91(1):185-95 PMID: 14689590
  9. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells.
    Exp Cell Res. 1997 May 1;232(2):208-15 PMID: 9168795
  10. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
    J Clin Endocrinol Metab. 1997 Jul;82(7):2198-203 PMID: 9215294
  11. Basic FGF, EGF, and PDGF modify TGFbeta-induction of smooth muscle cell phenotype in human prostatic stromal cells.
    Prostate. 1998 May;35(2):125-34 PMID: 9568676
  12. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
    Br J Cancer. 1998 Aug;78(4):554-6 PMID: 9716045
  13. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
    Cancer Res. 1999 Oct 1;59(19):5002-11 PMID: 10519415
  14. The stroma as a crucial target in rat mammary gland carcinogenesis.
    J Cell Sci. 2004 Mar 15;117(Pt 8):1495-502 PMID: 14996910
  15. Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation.
    Anat Rec. 1972 Feb;172(2):179-95 PMID: 5012433
  16. Stromal-epithelial interactions--I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice.
    J Steroid Biochem. 1981 Dec;14(12):1317-24 PMID: 6460136
  17. Epithelial-mesenchymal interactions in prostatic development. I. morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder.
    J Cell Biol. 1983 Jun;96(6):1662-70 PMID: 6853597
  18. Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma.
    Prog Clin Biol Res. 1984;145:81-102 PMID: 6371832
  19. The endocrinology and developmental biology of the prostate.
    Endocr Rev. 1987 Aug;8(3):338-62 PMID: 3308446
  20. In vitro studies of human prostatic epithelial cells: attempts to identify distinguishing features of malignant cells.
    Growth Factors. 1989;1(3):237-50 PMID: 2698220
Article Info
Journal
Endocrinology
Abbr.
Endocrinology
ISSN
0013-7227
Published
2005-01-00
Epub
2004-00-07
Pages
13-8
Language
English
Region
United States
NLM ID
0375040
PMCID
PMC3033046
Subset
IM
Grants
NCI NIH HHS · R01 CA101023-02 · United States
NCI NIH HHS · T32 CA079448 · United States
NCI NIH HHS · CA101023 · United States
NCI NIH HHS · R01 CA101023 · United States
NIDDK NIH HHS · DK52623 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com